[1]
“BREAKTHROUGH CAR-T THERAPY IN REFRACTORY B-CELL LYMPHOMA: MIOT INTERNATIONAL CHENNAI, INDIA CASE STUDY”, hncmc, pp. 143–144, May 2025, Accessed: Aug. 16, 2026. Available: https://www.hnchmc.uz/jour/article/view/182